Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Head Lice
Interventions: LICEMD, Standard Head lice product; Drug
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 3 Years to 12 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Alcoholism
Interventions: 125 mg AZD0530, 50 mg AZD0530, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Prostate Cancer
Interventions: Denosumab, Enzalutamide, Abiraterone, Prednisone; Biological · Drug
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Dry Eye Syndrome
Interventions: Preservative Free Saline, Optive, Refresh Moderate/Severe, Systane, Systane Ultra; Other
Lead sponsor: Gina Rogers; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Sudden Cardiac Death, Ventricular Tachycardia, Ventricular Fibrillation, Cardiomyopathy
Interventions: Cardiac Sympathetic Denervation (CSD), Routine Care; Procedure · Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Los Angeles, California • Portland, Oregon • Nashville, Tennessee

Conditions: Opioid-use Disorder, Suicidal Ideation
Interventions: Buprenorphine/Naloxone 8/2 milligram (mg) Sublingual Film, Morphine Sulfate 30 mg; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Abuse, Unspecified
Interventions: Opioid Naive, OR, At-risk for long-term use, OR, Long-term opioid recipient; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 555 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension
Interventions: olmesartan medoxomil, Placebo, losartan potassium; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 941 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 20
States / cities: Mesa, Arizona • Phoenix, Arizona • Harbor City, California + 17 more

Conditions: Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer
Interventions: Talazoparib Tosylate; Drug
Lead sponsor: Melinda Telli; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Stanford, California

Conditions: Huntington Disease, Chorea
Interventions: atomoxetine, Matching Placebo; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Anesthesia, Surgery, Knee Arthropathy
Interventions: Nonpharmacologic Treatment, Standard Care; Other
Lead sponsor: Durham VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older · Female only
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stroke
Interventions: Robotic therapy, Aerobic therapy; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 85 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Renal Cell Carcinoma
Interventions: Total consolidative MPDT; Procedure
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Deep Vein Thrombosis
Interventions: Apixaban, Placebo; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 3
States / cities: Rochester, Minnesota • Eau Claire, Wisconsin • La Crosse, Wisconsin

Conditions: HIV
Interventions: Leukapheresis; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2033
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Myelodysplastic Syndrome
Interventions: decitabine; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 4
States / cities: Canton, Ohio • Woonsocket, Rhode Island • Nashville, Tennessee + 1 more

Conditions: Gastroenterology Surgery, Tube Feeding
Interventions: Bearables Gastrostomy Tube Dressing; Device
Lead sponsor: Children's National Research Institute; Other
Eligibility: 7 Years to 21 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Hematologic Malignancy
Interventions: Reiki; Behavioral
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Post Operative Pain Management
Interventions: Scopolamine Patch (Transderm V); Drug
Lead sponsor: Alexander M Spiess, MD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 74 participants
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pre-Pectoral Breast Reconstruction Following Mastectomy
Interventions: AlloMend® Acellular Dermal Matrix allograft; Other
Lead sponsor: AlloSource; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Osteoarthritis, Hip Infection, Prosthetic Joint Infection, Complications; Arthroplasty, Infection or Inflammation, Complications; Arthroplasty
Interventions: Implantation of a static, non-articulating cement spacer., Implantation of an articulating spacer.; Procedure
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Traumatic Brain Injury, Upper Extremity Dysfunction, Disability Physical
Interventions: HAHE, Exergame; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 45 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Prosthesis User, Lower Limb Amputation Below Knee (Injury)
Interventions: Caesar Foot; Device
Lead sponsor: Liberating Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Austin, Texas

Search by objective public record fields.

Pediatric Head Lice Study Product Comparison

The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism

Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases

Tears Substitutions and Their Effects on Higher Order Aberrometery

Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias

Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder

Application of Economics & Social Psychology to Improve Opioid Prescribing Safety Trial 1: EHR Nudges

Olmesartan Comparison to Losartan in Hypertensive Subjects

Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

Atomoxetine and Huntington's Disease

Veterans Enhanced Recovery Using Integrative Treatments Around Surgery

The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

Robotic Pedaling Therapy for Targeted Neural Plasticity

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

Calf Deep Vein Thrombosis Treatment Trial

The Use of Leukapheresis to Support HIV Pathogenesis Studies

A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

Efficacy of a Novel Prototype Gastrostomy Tube Anchor Dressing

Reiki as a Complementary Therapy: A Pilot Study

A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery

Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement

TeleRehab to Restore Upper Limb Function in People With Chronic TBI

Caesar Foot Take-Home Validation Testing